Table 2.
WS-TCM | Usual care | ACU | P-value | |
---|---|---|---|---|
Non-donor cycles | ||||
Group, n | 119 | 580 | 370 | |
Number of days stimulateda,b | 9.8 ± 1.2 | 9.9 ± 1.2 | 9.9 ± 1.3 | NS |
Total gonadotrophin dose, IUa,b | 3959.3 ± 1503.6 | 3721.6 ± 1515.6 | 3932.1 ± 1580.1 | NS |
Peak oestradiol, pg/mla,b | 3153.7 ± 1781.8 | 3211.0 ± 1644.0 | 3017.0 ± 1634.0 | NS |
Endometrial thickness, mma,b | 10.9 ± 2.4 | 11.2 ± 2.4 | 11.2 ± 2.2 | NS |
Number of mature oocytes obtaineda,b,f | 14.0 ± 8.7 | 15.7 ± 9.1 | 14.2 ± 8.0 | 0.02 |
OHSS c,d | 8.4 | 9.5 | 7.1 | NS |
Fertilization methodc,d | ||||
Conventional | 47.1 | 51.0 | 46.3 | NS |
ICSI | 48.7 | 46.2 | 49.3 | NS |
Mixed | 4.2 | 2.8 | 4.3 | NS |
Pre-implantation genetic screeningc,d | 13.5 | 9.3 | 6.5 | NS |
Number of embryos transferreda,b,f | 2.9 ± 1.2 | 2.6 ± 1.1 | 2.8 ± 1.1 | 0.003 |
Day of embryo transferc,d | ||||
Day 3 | 64.7 | 59.7 | 65.7 | NS |
Day 5 | 35.3 | 40.3 | 34.3 | NS |
Mean number of acupuncture visitsa | 12.0 ±12.4 | |||
Donor cycles | ||||
Group, N | 21 | 104 | 37 | |
Peak oestradiol, pg/mla,b | 4303.9 ±2130.5 | 4250.3 ±2035.4 | 4428.4 ±2660.4 | NS |
Endometrial thickness, mma,b | 9.7 ±2.0 | 10.5 ±2.1 | 10.0 ±2.0 | NS |
Number of mature oocytes obtained from donora,b,f | 18.6 ±8.0 | 21.7 ±8.7 | 26.4 ±11.2 | 0.005 |
Fertilization method | ||||
Conventionalc,d | 57.1 | 60.6 | 67.6 | NS |
ICSIc,e | 38.1 | 33.7 | 27.0 | NS |
Mixedc,e | 4.8 | 5.8 | 5.4 | NS |
Pre-implantation genetic diagnosis Testingc,e | 4.8 | 10.6 | 8.3 | NS |
Number of embryos transferred a,b | 2.2 ±0.7 | 2.2 ±0.7 | 1.9 ±0.6 | NS |
Day of embryo transfer | ||||
Day 3c,e | 23.8 | 38.5 | 24.3 | NS |
Day 5c,d | 76.2 | 61.5 | 76.7 | NS |
Mean number of acupuncture visitsa | 10.6 ±13.6 |
Data are mean ± SD
Analysis of variance
Data are proportions
chi-squared
Fisher exact
Significant findings (P < 0.05)
ICSI, intracytoplasmic injection; OHSS, ovarian hyperstimulation syndrome